DBV Technologies SA (DBVT)
0.6959
+0.01
(+1.59%)
USD |
NASDAQ |
Sep 27, 16:00
0.69
-0.01
(-0.85%)
After-Hours: 20:00
DBV Technologies Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 2.23M |
June 30, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | |
June 30, 2019 | |
June 30, 2019 | |
December 31, 2018 | 0.00 |
June 30, 2018 | 0.0035M |
Date | Value |
---|---|
June 30, 2018 | 0.0035M |
December 31, 2017 | 1.518M |
June 30, 2017 | 0.0206M |
June 30, 2017 | 0.0206M |
December 31, 2016 | 1.315M |
June 30, 2016 | 11.14M |
June 30, 2016 | 11.14M |
December 31, 2015 | 0.00 |
June 30, 2015 | |
June 30, 2015 | |
December 31, 2014 | 0.1654M |
June 30, 2014 | 0.1775M |
June 30, 2014 | 0.1775M |
December 31, 2013 | 0.2527M |
June 30, 2013 | 0.0179M |
June 30, 2013 | 0.0179M |
December 31, 2012 | 0.1228M |
June 30, 2012 | 0.0538M |
December 31, 2011 | 0.001M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
2.23M
Maximum
Dec 2020
0.2787M
Average
--
Median
Dec 2019
Accounts Receivable (Quarterly) Benchmarks
Edap TMS SA | 19.52M |
Cellectis SA | 9.741M |
Genfit SA | 20.48M |
Adaptimmune Therapeutics PLC | 2.335M |
Akari Therapeutics PLC | -- |